Accidental Overdose in Pediatric Patient Taking Kaletra Oral Solution

Abbott Laboratories disseminated a Dear Healthcare Provider Letter throughout the world to physicians and pharmacists that prescribe/distribute Kaletra Oral Solution.

The letter informed healthcare professionals of an accidental overdose that occurred with a pediatric patient taking Kaletra Oral Solution.

The infant received a significantly large dose of Kaletra and subsequently died.

Healthcare professionals should pay special attention to accurate calculation of the dose of Kaletra, transcription of the medication order, dispensing information and dosing instructions to minimize the risk for medication errors.

Free Legal Review
Name:
Phone:
Email:
Case Description:

$423 million settlement— MTBE suit involving the contamination of 153 public water systems nationally

$16.5 million verdict — Asbestos case involving exposure from dental tape

$1.4 million settlement — Accident involving woman struck down by ambulance

$1.5 million settlement — for 47-year-old construction worker who fell off elevated train tracks

$25 million verdict —for New York City brake reliner who lost his right lung to mesothelioma

$6 million settlement — Pediatric malpractice involving infant who suffered brain damage at birth

$53 million verdict — brake mechanic suffering from mesothelioma

$13.5 million verdict — one of the very first Vioxx trial cases

$15 million settlement — man wound up a paraplegic due to negligent hospital care

$37 million verdict — 2 asbestos lung cancer plaintiffs

$47 million verdict — boilermaker who died from mesothelioma

$2.6 million settlement — ill-fitting prosthesis caused decubitus ulcers

$75 million verdict — historic consolidated trial involving men who had worked at the Brooklyn Navy Yard in the 1940s and 1950s

$12.7 million verdict — iron worker who was injured due to unsafe working conditions

$8 million settlement — obstetrical malpractice resulted in neurological deficits

$64.65 million award — 4 asbestos plaintiffs

$17.5 million — consolidated trial of 5 mesothelioma victims